Sage Therapeutics shares owned by GSA Capital Partners
Quarter-by-quarter ownership of Sage Therapeutics (SAGE) shares owned by GSA Capital Partners
from 13F filings
Historical chart of GSA Capital Partners investment in Sage Therapeutics
Tip: Access up to 7 years of quarterly data
All positions including Sage Therapeutics held by GSA Capital Partners consolidated in one spreadsheet with up to 7 years of data
Download as csv Download as ExcelQuarterly reported holdings in Sage Therapeutics by GSA Capital Partners
Quarter filed | Position value | Share count | Share price at filing |
---|---|---|---|
2024-03-31 | $218k | 12k | 18.70 |
2023-12-31 | $1.5M | 70k | 21.67 |
2023-03-31 | $450k | 11k | 41.97 |
2022-09-30 | $531k | 14k | 39.17 |
2022-06-30 | $606k | 19k | 32.32 |
2021-12-31 | $1.1M | 26k | 42.56 |
2021-09-30 | $371k | 8.4k | 44.32 |
2021-06-30 | $987k | 17k | 56.79 |
2020-12-31 | $561k | 6.5k | 86.48 |
2020-09-30 | $290k | 4.7k | 61.13 |
2020-03-31 | $614k | 21k | 28.73 |
2019-12-31 | $445k | 6.2k | 72.16 |
2015-06-30 | $409k | 5.6k | 73.04 |